# Anti-reflux Mucosal Ablation Therapy Randomized Sham Control Trial for Gastroesophageal Reflux Disease

> **NCT06106100** · NA · NOT_YET_RECRUITING · sponsor: **Far Eastern Memorial Hospital** · enrollment: 68 (estimated)

## Conditions studied

- Gastroesophageal Reflux Disease

## Interventions

- **PROCEDURE:** Antireflux mucosal ablation
- **PROCEDURE:** Sham procedure

## Key facts

- **NCT ID:** NCT06106100
- **Lead sponsor:** Far Eastern Memorial Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-03
- **Primary completion:** 2026-10
- **Final completion:** 2027-10
- **Target enrollment:** 68 (ESTIMATED)
- **Last updated:** 2024-02-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06106100

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06106100, "Anti-reflux Mucosal Ablation Therapy Randomized Sham Control Trial for Gastroesophageal Reflux Disease". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06106100. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*